At a glance
ClinicalIndex Comparison RecordN/ACompleted· 135 enrolled
Drug / intervention
PAP therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Trial of Positive Airway Pressure Therapy to Treat Cognitive Dysfunction in MS Patients With Obstructive Sleep Apnea
In Brief
A clinical study evaluating PAP therapy for Multiple Sclerosis. Completed, enrolled 135 participants across 1 site.
Detailed Summary
The objectives of this study are to determine the effects of obstructive sleep apnea (OSA) on cognitive function in patients with multiple sclerosis (MS); and to evaluate whether OSA treatment with positive airway pressure therapy could improve cognitive dysfunction in MS patients who have OSA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
CollaboratorsNational Multiple Sclerosis Society
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 2015
Enrollment StartNov 2015
Primary CompletionJun 2021
TodayJul 2026
First PostedSep 9, 2015
Enrollment StartNov 12, 2015
Primary CompletionJun 25, 2021
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 10.8 years ago
Interventions
PAP therapydevice
Positive airway pressure treatment for obstructive sleep apnea